ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL (ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZO) — FDA Approval ANDA062759 (BARR)
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL (ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZO) — FDA Approval ANDA062759 (BARR) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL; Active ingredients: ERYTHROMYCIN ETHYLSUCCINATE; S
| Brand name | ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL |
|---|---|
| Active ingredients | ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL |
| Application number | ANDA062759 |
| Sponsor | BARR |
| Dosage form | GRANULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19880520 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →